MARCKS PSD-Derived Peptide, PKC Substrate
CAS No. ———
MARCKS PSD-Derived Peptide, PKC Substrate( ——— )
Catalog No. M41692 CAS No. ———
MARCKS PSD-Derived Peptide, PKC Substrate
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMARCKS PSD-Derived Peptide, PKC Substrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMARCKS PSD-Derived Peptide, PKC Substrate
-
DescriptionMARCKS PSD-Derived Peptide, PKC Substrate
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1543.93
-
Molecular FormulaC75H122N20O15
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
5β-Hydroxybufotalin
5β-Hydroxybufotalin (compound 6) is an anticancer agent that can effectively inhibit the growth activity of cancer cells. 5β-Hydroxybufotalin is also a natural product obtained from the chinese traditional drug Ch'an Su.
-
Trityl candesartan c...
Trityl candesartan cilexetil
-
MW01-2-151SRM
MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.
Cart
sales@molnova.com